Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Target tissue antibiotic concentration in CABG using left internal mammary artery
2009-016532-12Phase 2Completed
- Sponsor
- Medical University of Vienna
- Start
- Dec 2009
- Modality
- Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of cefazolin and teicoplanin in coronary arteriosclerosis and Deep sternal wound infection (DSWI), sponsored by Medical University of Vienna. Primary endpoint: Difference of tissue concentration of teicoplanin between left and right pre-sternal subcutaneous tissue and thigh subcutaneous tissue. Started Dec 2009; status: completed.
02
Drugs
cefazolinteicoplanin
03
Conditions
coronary arteriosclerosisDeep sternal wound infection (DSWI)
Beyond the preview
Go deeper on 2009-016532-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-016532-12.